scholarly journals P463The long-term risk of heart failure hospitalization after surgical and transcatheter valve replacement

EP Europace ◽  
2017 ◽  
Vol 19 (suppl_3) ◽  
pp. iii103-iii103
Author(s):  
A. Zegard ◽  
T. Qiu ◽  
D. Mcnulty ◽  
F. Evison ◽  
H. Marshall ◽  
...  
2020 ◽  
Vol 21 (8) ◽  
pp. 982-985 ◽  
Author(s):  
Mohammad Al-Akchar ◽  
Khalid Sawalha ◽  
Hadi Mahmaljy ◽  
Abdisamad M. Ibrahim ◽  
Mohsin Salih ◽  
...  

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
M Seo ◽  
T Yamada ◽  
T Watanabe ◽  
T Morita ◽  
Y Furukawa ◽  
...  

Abstract Background Cardiac sympathetic nerve dysfunction, which is assessed by I-123 metaiodobenzylguanidine (MIBG) imaging, is associated with the poor outcomes in patients with chronic heart failure (CHF). Serial evaluation of cardiac MIBG imaging was shown to be useful for predicting adverse outcome in CHF. However, there was no information available on long-term serial changes of cardiac sympathetic nerve dysfunction after discharge of acute decompensated heart failure (ADHF) hospitalization. Purpose We aimed to clarify the serial change of cardiac MIBG imaging parameter in long-term after discharge of heart failure hospitalization, especially relating to HFrEF (LVEF<40%), HFmrEF (40%≤LVEF<50%) and HFpEF (LVEF≥50%). Methods We studied 112 patients (HFrEF; n=44, HFmrEF; n=23 and HFpEF; n=45) who were admitted for ADHF, discharged with survival and without heart failure hospitalization during follow-up period. All patients underwent cardiac MIBG imaging at the timing of discharge, in 6–12 months and in 18–24 months after discharge. The cardiac MIBG heart to mediastinum ratio (H/M) was calculated on the early image and the delayed image (late H/M). The cardiac MIBG washout rate (WR) was calculated from the early and delayed planar images after taking radioactive decay of I-123 into consideration. Results In HFrEF patients, late H/M was significantly improved from discharge to 6–12 months data (1.60±0.24 vs 1.75±0.31, p<0.0001). Late H/M of HFmrEF patients was also significantly improved from discharge to 18–24 months data (1.71±0.27 vs 1.84±0.29 p=0.043). On the other hand, late H/M of HFpEF patients was not significantly changed. As for WR, WR in HFrEF and HFmrEF patients was significantly improved from discharge to 18–24 months data, although WR of HFpEF was not significantly changed. Conclusion The improvement in cardiac sympathetic nerve dysfunction was observed in patients with HFrEF and HFmrEF, not in HFpEF, after the discharge of acute heart failure hospitalization. Funding Acknowledgement Type of funding source: None


2013 ◽  
Vol 6 (6) ◽  
pp. e33-e34 ◽  
Author(s):  
Vijayakumar Subban ◽  
Alexander Incani ◽  
Andrew Clarke ◽  
Constantine Aroney ◽  
Gregory M. Scalia ◽  
...  

Herz ◽  
2015 ◽  
Vol 41 (2) ◽  
pp. 144-150 ◽  
Author(s):  
V. Kamperidis ◽  
S. Hadjimiltiades ◽  
S.A. Mouratoglou ◽  
A. Ziakas ◽  
G. Sianos ◽  
...  

Author(s):  
Jörg Kempfert ◽  
Thomas Walther

The natural history of untreated severe aortic valve stenosis (AS), with an average survival of 3 years after the onset of angina or syncope and only 1½ years after onset of heart failure, strongly suggests early surgical therapy which represents the only curative option. Since the first pioneering work in the early 1960s, conventional aortic valve replacement (AVR) has become a routine procedure performed more than 200,000 times annually worldwide. The surgical technique of AVR has evolved to a highly standardized procedure resulting in excellent outcome and patient safety. Transcatheter techniques have emerged in the last decade allowing for valve implantation with avoidance of important complications of major surgery particularly in high-risk patients. However, potential drawbacks and procedure-related complications remain important. The techniques and technologies continue to emerge and improve. Conventional surgery, valve substitutes, and transcatheter technologies are discussed in this chapter.


Sign in / Sign up

Export Citation Format

Share Document